Sounding The Alarm On The Future Of CNS Drug Development
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The drug development paradigm for new central nervous system therapeutics is in need of a thorough reimagining, Tufts Center for the Study of Drug Development researchers assert in an analysis published in Scientific American.